University of Montana researchers recently published their new insights into how pathogenic bacteria resist antibiotic treatment in Proceedings of the Natural Academy of Sciences.
"Antibiotic resistance is a major problem," said Patrick Secor, assistant professor in UM's Division of Biological Sciences and lead researcher on the paper. "However, it is often the case that if you take bacteria that survive antibiotic treatment from someone's infected lungs and treat those same bacteria with antibiotics in the lab, the bacteria die. We wanted to understand why."
Secor and researchers at UM and the University of Washington discovered that polymers present in airway mucus physically push on bacterial cells.
"We found that bacteria living in high concentrations of polymers get a little stressed out," said Lia Michaels, a researcher at UM and co-author of the paper. "Basically, the polymer-rich environment activates stress responses in the bacteria, causing them to tolerate higher levels of antibiotics."
"I like to compare it to the stress our bodies undergo when we exercise," Secor said. "Exercising today allows you to run a little further or lift a little more weight later on. This is analogous to the stress responses turned on in bacteria living in airway mucus - exposure to stress today allows the bacteria to survive the stress of antibiotic exposure later on."
The researchers discovered that stress responses induced by mucus polymers pressing on the bacteria were a result of mild DNA damage in the bacterial cells.
"One thing that this DNA damage did was slow bacterial growth," said Laura Jennings, UM research assistant professor and co-author of the paper. "Because most antibiotics work best on rapidly dividing cells, these slow-growing bacteria were more difficult to kill with antibiotics."
The researchers speculate that the mechanisms by which polymers turn on bacterial stress responses could be targeted therapeutically to treat long-term bacterial infections.
"Our hope is that we could come up with new ways to treat bacterial infections or increase the efficacy of antibiotic treatment," Secor said.
The paper, "Entropically-driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa," is online at http://www.pnas.org/content/early/2018/09/27/1806005115.
Source: University of Montana
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.
Avian Flu Risks in Veterinary Practice: Protecting Those on the Frontlines
January 6th 2025Veterinarians, technicians, and veterinarian infection preventionists face risks from H5N1 avian flu when handling farm animals or exposed wildlife. Learn key prevention strategies, PPE recommendations, and emerging challenges.
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.